Highvista Strategies LLC / OPHTEUR
Highvista Strategies LLC’s Iveric Bio Inc Position
Does Highvista Strategies LLC own Iveric Bio Inc (OPHTEUR)? Not currently — the last reported position was 139.6K shares worth $5M in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$5M
Q2 2023
Shares
139.6K
% of Portfolio
+2.51%
Quarters Held
12
position exited
Position History OPHTEUR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2023 | 139.6K | $5M | +2.51% |
| Q1 2023 | 98.1K | $2M | +1.94% |
| Q4 2022 | 98.1K | $2M | +1.25% |
| Q3 2022 | 34.1K | $611,000 | +0.35% |
| Q2 2022 | 57.9K | $557,000 | +0.34% |
| Q1 2022 | 53.6K | $902,000 | +0.57% |
| Q4 2021 | 101.1K | $2M | +1.35% |
| Q3 2021 | 63.1K | $1M | +0.68% |
| Q2 2021 | 119.0K | $751,000 | +0.53% |
| Q1 2021 | 141.1K | $872,000 | +0.65% |
| Q4 2020 | 117.1K | $809,000 | +0.52% |
| Q3 2020 | 96.0K | $541,000 | +0.39% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of OPHTEUR.